Affordable Access

Publisher Website

Interleukin-17 regulation: an attractive therapeutic approach for asthma

Authors
Journal
BMJ Open Respiratory Research
1465-9921
Publisher
BMJ
Publication Date
Volume
11
Issue
1
Identifiers
DOI: 10.1186/1465-9921-11-78
Keywords
  • Review
Disciplines
  • Medicine

Abstract

Interleukin (IL)-17 is recognized to play a critical role in numerous immune and inflammatory responses by regulating the expression of various inflammatory mediators, which include cytokines, chemokines, and adhesion molecules. There is growing evidence that IL-17 is involved in the pathogenesis of asthma. IL-17 orchestrates the neutrophilic influx into the airways and also enhances T-helper 2 (Th2) cell-mediated eosinophilic airway inflammation in asthma. Recent studies have demonstrated that not only inhibitor of IL-17 per se but also diverse regulators of IL-17 expression reduce antigen-induced airway inflammation, bronchial hyperresponsiveness, and Th2 cytokine levels in animal models of asthma. This review will summarize the role of IL-17 in the context of allergic airway inflammation and discuss the therapeutic potential of various strategies targeting IL-17 for asthma.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Role of interleukin-17F in asthma.

on Inflammation & allergy drug ta... December 2009

Expression of interleukin (IL)-17F in a mouse mode...

on Journal of Allergy and Clinica... Jan 01, 2004
More articles like this..